Tactile Medical to Present at the Guggenheim 2021 MedTech Disruptors Summit
August 04 2021 - 4:05PM
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:
TCMD), a medical technology company focused on developing medical
devices for the treatment of chronic diseases at home, today
announced that management will participate in the Guggenheim 2021
MedTech Disruptors Summit, which is being held virtually from
August 9th-10th. Management will participate in a fireside chat on
Monday, August 9th at 3:00 p.m. Eastern Time.
About Tactile
Medical
Tactile Medical is a leader in developing and marketing at-home
therapy devices that treat chronic swelling conditions such as
lymphedema and chronic venous insufficiency. Tactile Medical’s
Mission is to help people suffering from chronic diseases live
better and care for themselves at home. The Company’s unique
offering includes advanced, clinically proven pneumatic compression
devices, as well as continuity of care services provided by a
national network of product specialists and trainers, reimbursement
experts, patient advocates and clinicians. This combination of
products and services ensures that tens of thousands of patients
annually receive the at-home treatment necessary to better manage
their chronic conditions. Tactile Medical takes pride in the fact
that our solutions help increase clinical efficacy, reduce overall
healthcare costs and improve the quality of life for patients with
chronic conditions.
Investor Inquiries:
Mike Piccinino, CFA
Managing Director
Westwicke
investorrelations@tactilemedical.com
Tactile Systems Technology (NASDAQ:TCMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tactile Systems Technology (NASDAQ:TCMD)
Historical Stock Chart
From Apr 2023 to Apr 2024